Edward A. Hirschowitz

1.8k total citations
30 papers, 1.5k citations indexed

About

Edward A. Hirschowitz is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Edward A. Hirschowitz has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Edward A. Hirschowitz's work include Virus-based gene therapy research (11 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Research and Treatments (6 papers). Edward A. Hirschowitz is often cited by papers focused on Virus-based gene therapy research (11 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Research and Treatments (6 papers). Edward A. Hirschowitz collaborates with scholars based in United States. Edward A. Hirschowitz's co-authors include Ronald G. Crystal, Arnold J. Stromberg, Li Zhong, John R. Yannelli, Nada H. Khattar, James R. Jett, Akihiko Ohwada, Ben‐Gary Harvey, Jamie Sturgill and Dennis E. Doherty and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Edward A. Hirschowitz

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward A. Hirschowitz United States 19 835 545 489 446 286 30 1.5k
Stephen L. Eck United States 21 591 0.7× 400 0.7× 498 1.0× 283 0.6× 113 0.4× 35 1.3k
Leopoldo Luistro United States 15 777 0.9× 1.0k 1.9× 305 0.6× 1.1k 2.5× 281 1.0× 28 2.2k
Gustav Ullenhag Sweden 24 633 0.8× 1.1k 2.1× 291 0.6× 837 1.9× 149 0.5× 97 1.8k
Kang Hu China 19 618 0.7× 536 1.0× 532 1.1× 216 0.5× 73 0.3× 27 1.3k
Sara Bobisse Switzerland 19 1.1k 1.3× 1000 1.8× 164 0.3× 667 1.5× 211 0.7× 31 1.8k
Leia M. Smith United States 21 893 1.1× 830 1.5× 170 0.3× 416 0.9× 535 1.9× 31 1.9k
Stefanie Mandl United States 14 789 0.9× 442 0.8× 148 0.3× 234 0.5× 94 0.3× 25 1.4k
Patrice Yeh France 21 1.1k 1.3× 371 0.7× 750 1.5× 109 0.2× 112 0.4× 25 1.6k
Dongshu Chen United States 19 1.7k 2.0× 1.1k 2.0× 224 0.5× 1.7k 3.8× 357 1.2× 22 2.7k
Mateusz Opyrchal United States 23 694 0.8× 1.0k 1.9× 327 0.7× 406 0.9× 67 0.2× 101 1.8k

Countries citing papers authored by Edward A. Hirschowitz

Since Specialization
Citations

This map shows the geographic impact of Edward A. Hirschowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Hirschowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Hirschowitz more than expected).

Fields of papers citing papers by Edward A. Hirschowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward A. Hirschowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Hirschowitz. The network helps show where Edward A. Hirschowitz may publish in the future.

Co-authorship network of co-authors of Edward A. Hirschowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Edward A. Hirschowitz. A scholar is included among the top collaborators of Edward A. Hirschowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward A. Hirschowitz. Edward A. Hirschowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khattar, Nada H., et al.. (2014). Autoantibody Profiling for Lung Cancer Screening Longitudinal Retrospective Analysis of CT Screening Cohorts. PLoS ONE. 9(2). e87947–e87947. 12 indexed citations
2.
Hirschowitz, Edward A., et al.. (2010). Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer. Journal of Thoracic Oncology. 6(1). 169–173. 16 indexed citations
3.
Hirschowitz, Edward A. & John R. Yannelli. (2009). Immunotherapy for Lung Cancer. Proceedings of the American Thoracic Society. 6(2). 224–232. 37 indexed citations
4.
Zhong, Li, et al.. (2006). Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1(6). 513–519. 125 indexed citations
5.
Zhong, Li, et al.. (2005). Using Protein Microarray as a Diagnostic Assay for Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 172(10). 1308–1314. 74 indexed citations
6.
Yannelli, John R., et al.. (2004). The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC). Lung Cancer. 47(3). 337–350. 18 indexed citations
7.
Zhong, Li, et al.. (2003). Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detection and Prevention. 27(4). 285–290. 51 indexed citations
8.
Shih, Wei-Jen, et al.. (2002). Biodistribution on Tc-99m labeled somatostatin receptor-binding peptide (Depreotide, NeoTec) planar and SPECT studies. Annals of Nuclear Medicine. 16(3). 213–219. 19 indexed citations
9.
Hirschowitz, Edward A., et al.. (2002). Induction of Cyclo-oxygenase-2 in Non-small Cell Lung Cancer cells by Adenovirus Vector Infection. CHEST Journal. 121(3). 32S–32S. 5 indexed citations
10.
Shih, Wei-Jen, et al.. (2002). Comparative SPECT Findings of Tc-99m Depreotide, Tc-99m Tetrofosmin, and Tl-201 Chloride for Bronchogenic Carcinoma. Clinical Nuclear Medicine. 27(9). 676–679. 4 indexed citations
12.
Hirschowitz, Edward A., Hassan A. Naama, Denis Evoy, et al.. (1999). Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma. Cancer Gene Therapy. 6(6). 491–498. 12 indexed citations
13.
Hirschowitz, Edward A. & Ronald G. Crystal. (1999). Adenovirus-Mediated Expression of Interleukin-12 Induces Natural Killer Cell Activity and Complements Adenovirus-Directed gp75 Treatment of Melanoma Lung Metastases. American Journal of Respiratory Cell and Molecular Biology. 20(5). 935–941. 13 indexed citations
14.
Ross, Howard M., Edward A. Hirschowitz, Ronald G. Crystal, et al.. (1997). Adenoviral Thymidine Kinase Prodrug Gene Therapy Inhibits Sarcoma Growthin Vivo. Journal of Surgical Research. 70(1). 7–11. 3 indexed citations
15.
Hirschowitz, Edward A., et al.. (1997). Delayed-Type Hypersensitivity Response to High Doses of Adenoviral Vectors. Human Gene Therapy. 8(3). 323–330. 10 indexed citations
18.
Wen, Patrick Y., Yoshinobu Manome, Michael Parr, et al.. (1996). In Vivo Replication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-Fluorocytosine. Human Gene Therapy. 7(6). 713–720. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026